Primary diffuse large B cell lymphoma arising from a leiomyoma of the uterine corpus

Diagn Pathol. 2016 Jan 20:11:9. doi: 10.1186/s13000-016-0464-8.

Abstract

Background: Primary diffuse large B cell lymphoma (DLBCL) of the uterus is rare, and primary DLBCL arising from a uterine leiomyoma (collision tumor) has not been reported in the literature.

Case presentation: We describe the clinical, histological, immunohistochemical, and molecular features of primary DLBCL arising from a leiomyoma in the uterine corpus. A 73-year-old female patient had a uterine mass for 23 years. An ultrasound scan revealed marked enlargement of the uterus, measuring 18.2 × 13 × 16.3 cm, with a 17.6 × 10.9 × 11.6 cm hypoechoic mass in the uterine corpus. The tumors consisted of medium- to large-sized cells exhibiting a diffuse pattern of growth with a well-circumscribed leiomyoma. The neoplastic cells strongly expressed CD79α, CD20 and PAX5. Molecular analyses indicated clonal B-cell receptor gene rearrangement.

Conclusions: To the best of our knowledge, no previous cases of primary DLBCL arising from a leiomyoma have been reported. It is necessary to differentiate a diagnosis of primary DLBCL arising from a leiomyoma from that of leiomyoma with florid reactive lymphocytic infiltration (lymphoma-like lesion). Careful analysis of clinical, histological, immunophenotypic, and genetic features is required to establish the correct diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Biopsy
  • Female
  • Gene Rearrangement, B-Lymphocyte
  • Humans
  • Immunohistochemistry
  • Leiomyoma / chemistry
  • Leiomyoma / genetics
  • Leiomyoma / pathology*
  • Leiomyoma / surgery
  • Lymphoma, Large B-Cell, Diffuse / chemistry
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Lymphoma, Large B-Cell, Diffuse / surgery
  • Neoplasm Staging
  • Neoplasms, Multiple Primary / chemistry
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Multiple Primary / pathology*
  • Neoplasms, Multiple Primary / surgery
  • Predictive Value of Tests
  • Tumor Burden
  • Uterine Neoplasms / chemistry
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / pathology*
  • Uterine Neoplasms / surgery

Substances

  • Biomarkers, Tumor